FXAIX
Price
$265.83
Change
-$2.30 (-0.86%)
Updated
Aug 20 closing price
Net Assets
833.14B
PTMCX
Price
$20.25
Change
+$0.10 (+0.50%)
Updated
Aug 21 closing price
Net Assets
1.07B
Interact to see
Advertisement

FXAIX vs PTMCX

FXAIX vs PTMCX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. PTMCX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a StrongBuy and PTMCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 833B vs. PTMCX (1.07B). FXAIX pays higher dividends than PTMCX: FXAIX (1.06) vs PTMCX (0.18). FXAIX was incepted earlier than PTMCX: FXAIX (15 years) vs PTMCX (27 years). PTMCX (1.64) is less costly to investors than FXAIX (0.01). PTMCX is a more actively managed with annual turnover of: 123.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than PTMCX: FXAIX (0) vs PTMCX (1000). FXAIX annual gain was more profitable for investors over the last year : 21.35 vs. PTMCX (7.98). FXAIX return over 5 years is better than : 84.67 vs. PTMCX (14.70).
FXAIXPTMCXFXAIX / PTMCX
Total Expense Ratio0.011.441%
Annual Report Gross Expense Ratio0.011.641%
Fund Existence15 years27 years-
Gain YTD12.43713.50992%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets833B1.07B77,923%
Annual Yield % from dividends1.060.18591%
Returns for 1 year21.357.98268%
Returns for 3 years81.1537.10219%
Returns for 5 years84.6714.70576%
Returns for 10 years286.5742.56673%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX55.570.84
+1.53%
Rydex Biotechnology C
RSLBX70.040.57
+0.82%
American Funds SMALLCAP World R-2
RYPNX20.180.16
+0.80%
Royce Small-Cap Opportunity Invmt
VSORX54.480.35
+0.65%
Victory Sycamore Small Company Opp R6
BLNIX15.060.05
+0.33%
Meeder Balanced Institutional